MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Medline Inc.
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 5, 2026
$35.19−0.77 (-2.14%)
Close on Oct 19, 2026
- Market cap
- $30.29B
- P/E (TTM)
- –
- Dividend yield
- –
Medline statistics
Financials through Jun 27, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Medline | Industry median |
|---|---|---|
| Market Cap | $46.26B | $230.55M |
| Enterprise Value | $63.67B | $202.97M |
| PS Ratio | 1.63 | 3.10 |
| PB Ratio | 4.00 | 3.04 |
| P/FCF Ratio | 35.67 | 27.30 |
| P/OCF Ratio | 26.53 | 22.47 |
Enterprise value
| Measure | Medline | Industry median |
|---|---|---|
| EV / Sales | 2.24 | 2.91 |
| EV / EBITDA | 19.75 | 19.74 |
| EV / EBIT | 28.78 | 24.80 |
| EV / FCF | 49.09 | 27.89 |
Income (trailing twelve months)
| Measure | Medline | Industry median |
|---|---|---|
| Revenue | $28.43B | $102.39M |
| Gross Profit | $7.52B | $60.36M |
| Operating Income | $2.21B | -$4.31M |
| Pretax Income | $1.25B | -$2.37M |
| Net Income | $1.16B | -$6.57M |
| EBITDA | $3.22B | -$1.98M |
| EPS (Diluted) | -$0.01 | -$0.08 |
Margins
| Measure | Medline | Industry median |
|---|---|---|
| Gross Margin | 26.4% | 55.2% |
| Operating Margin | 7.78% | -6.04% |
| Pretax Margin | 4.39% | -4.11% |
| Profit Margin | 4.08% | -10.5% |
| EBITDA Margin | 11.3% | -2.67% |
| FCF Margin | 4.56% | 0.02% |
Returns
| Measure | Medline | Industry median |
|---|---|---|
| Return on Equity (ROE) | 10.0% | -18.2% |
| Return on Assets (ROA) | 2.95% | -13.3% |
| Return on Invested Capital (ROIC) | 9.55% | -3.69% |
| Return on Capital Employed (ROCE) | 6.04% | -9.07% |
Growth
| Measure | Medline | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 11.5% | 8.85% |
| FCF Growth (YoY) | -8.34% | 9.68% |
Balance sheet
| Measure | Medline | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.68B | $36.66M |
| Total Debt | $12.58B | $97.65M |
| Net Cash (Debt) | -$9.90B | $3.92M |
| Net Cash Per Share | -$7.53 | $0.28 |
| Equity (Book Value) | $11.57B | $55.33M |
| Book Value Per Share | $8.80 | $2.87 |
| Tangible Book Value | -$10.04B | $10.79M |
| Working Capital | $9.03B | $56.72M |
Financial position
| Measure | Medline | Industry median |
|---|---|---|
| Current Ratio | 4.33 | 2.48 |
| Quick Ratio | 2.34 | 1.53 |
| Debt / Equity | 1.09 | 0.41 |
| Debt / EBITDA | 3.90 | 2.40 |
| Debt / FCF | 9.70 | 3.49 |
| Net Debt / EBITDA | 3.07 | 1.53 |
| Interest Coverage | 2.34 | -1.85 |
Cash flow (trailing twelve months)
| Measure | Medline | Industry median |
|---|---|---|
| Operating Cash Flow | $1.74B | -$566.22K |
| Capital Expenditures | -$447.00M | -$3.69M |
| Free Cash Flow | $1.30B | -$696.00K |
| FCF Per Share | $0.99 | -$0.02 |
Efficiency
| Measure | Medline | Industry median |
|---|---|---|
| Asset Turnover | 0.72 | 0.58 |
| Inventory Turnover | 4.48 | 2.21 |
| Revenue Per Employee | $631.82K | $322.92K |
| Profits Per Employee | $25.76K | -$51.88K |
| Employee Count | 45,000 | 185 |
Dividends and yields
| Measure | Medline | Industry median |
|---|---|---|
| Earnings Yield | 2.51% | -6.88% |
| FCF Yield | 2.80% | -0.45% |
| Buyback Yield | 0.07% | 0.78% |
| Shareholder Yield | 0.07% | 0.80% |
Shares
| Measure | Medline | Industry median |
|---|---|---|
| Shares Outstanding | 1,314,710,000 | 44,302,700 |
| Float | 197,235,000 | 37,462,700 |
| Shares Held by Insiders | 85.0% | 10.5% |
| Shares Held by Institutions | 57.1% | 63.5% |
Taxes
| Measure | Medline | Industry median |
|---|---|---|
| Income Tax | $91.00M | $1.52M |
| Effective Tax Rate | 7.29% | 18.5% |
Scores
| Measure | Medline | Industry median |
|---|---|---|
| Altman Z-Score | 2.56 | 1.95 |
| Beneish M-Score | -2.39 | -2.64 |
Calculated by StockData from Medline's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.